Skip to content
DataLookout
Menu

Sichuan Baili Pharmaceutical Co., Ltd. clinical trial pipeline

Get alerts when Sichuan Baili Pharmaceutical Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

6 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 3 with minor changes only.

  1. Minor: BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment · EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04) Enrollment closed, study ongoing Sichuan Baili Pharmaceutical Co., Ltd.Phase 3 NCT06838273
  2. Notable: BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line · Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05) Recruitment opened Sichuan Baili Pharmaceutical Co., Ltd.Phase 2/3 NCT07739199
  3. Notable: BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06) Recruitment opened Sichuan Baili Pharmaceutical Co., Ltd.Phase 2/3 NCT07739186
  4. Notable: BL-M08D · Locally Advanced or Metastatic Melanoma and Other Solid Tumors Recruitment opened Sichuan Baili Pharmaceutical Co., Ltd.Phase 1/2 NCT07841925
  5. Minor: BL-M07D1 · Recurrent or Metastatic Gynecologic Malignancies Enrollment increased: 138 → 158 participants Sichuan Baili Pharmaceutical Co., Ltd.Phase 1/2 NCT06131450
  6. Minor: BL-B01D1 With Chemotherapy of Physician's Choice · Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01) Enrollment closed, study ongoing Sichuan Baili Pharmaceutical Co., Ltd.Phase 3 NCT06857175
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1
43
Phase 1/2
19
Phase 2
35
Phase 2/3
8
Phase 3
26

Disease areas by active trials, top 10 of 32

Get alerts when Sichuan Baili Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free